Social Sentiment Ticker Powered by AI
Social Sentiment Ticker Powered by AI
Download App
Master the Markets with TradeZing PLUS’s AI Powered Tools
Learn More
Host your events on tradezing app
COMMUNITY AUDIO ROOMS
No available audio rooms
Upcoming Events
Sell in May and walk away from crypto?!? $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCO $BTCW $GBTC
Sell in May and walk away from crypto?!? $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCO $BTCW $GBTC
0 Day3 Hr31 Min24 Sec
YouTube
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
Bitcoins next massive move will shock investors!!! $BTC $BITI $BITO $HODL $IBIT $ARKB $BTCW $GBTC
21 Day3 Hr31 Min24 Sec
YouTube
Get the TradeZing Newsletter
Supercharge
Your Money Making Potential
Watch your wealth rise with the power of AI research tools only with TradeZing PLUS!
Subscribe Now
EXCLUSIVE
Trade the Day
With Larry Benedict and Eric Shamilov
Trade together with legendary hedge fund manager Larry Benedict every morning before the bell
Everyday at 8:45 AM EST
What is Trade the Day?
Get ahead of the market curve each trading day with Larry Benedict, a distinguished Barron’s Top 100 hedge fund manager and the founder of the Opportunistic Trader ETF (WZRD). With his analyst, Eric Shamilov, Larry provides live, pre-market trading insights and strategic analysis, equipping you with the knowledge to make smart trading decisions.
Not a TradeZing PRO Member?
Subscribe now for exclusive advantages and benefits!
Latest Feed
May 3, 2024
26 mins ago
Alignment Healthcare Is ‘Differentiated With Durable Long-Term Growth Trajectory’ In Challenging Medicare Advantage Environment: Analyst Says
On Thursday, Alignment Healthcare Inc (NASDAQ:ALHC) reported a first-quarter EPS loss of $(0.25), up from $(0.20) a year ago, missing the consensus of $(0.22). The company reported sales of $628.6 million, up 43.1% Y/Y, beating the consensus of $595.13 million and the management guidance of $590 million-$600 million. The medical benefits ratio based on adjusted gross profit was 90.9%. Health plan membership at the end of the quarter was approximately 165,100, up 50.5% Y/Y. Guidance: Alignment Healthcare expects Q2 revenues of $625 million—$635 million versus the consensus of $608.65 million. The company raised its fiscal year 2024 sales outlook from $2.38 billion—$2.41 billion to $2.495 billion—$2.525 billion, compared to the …Full story available on Benzinga.com
175241
News
May 3, 2024
27 mins ago
Analyst Expectations For Zimmer Biomet Holdings’s Future
In the last three months, 9 analysts have published ratings on Zimmer Biomet Holdings (NYSE:ZBH), offering a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 6 1 0 Last 30D 0 1 1 0 0 1M Ago 0 0 2 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 3 1 0 Analysts have set 12-month price targets for Zimmer Biomet Holdings, revealing an average target of $135.0, a high estimate of $155.00, and a low estimate of $125.00. Observing a 3.39% increase, the current average has risen from the previous average price target of $130.57. Decoding Analyst Ratings: A Detailed Look The standing of Zimmer Biomet Holdings among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Richard Newitter Truist Securities Lowers Hold $130.00 $137.00 Steven Lichtman Oppenheimer Raises Outperform $155.00 $150.00 Vijay Kumar Evercore ISI Group Raises In-Line $130.00 $125.00 Joanne Wuensch Citigroup Raises Neutral $140.00 $134.00 Caitlin Cronin Canaccord Genuity Maintains Hold $130.00 – Matt Miksic Barclays Raises Underweight $130.00 $120.00 Richard Newitter Truist Securities Raises Hold $135.00 $133.00 Robbie Marcus JP Morgan Raises Neutral $125.00 $115.00 Shagun Singh RBC Capital Maintains Outperform $140.00 – Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, it reflects their response to recent developments related to Zimmer …Full story available on Benzinga.com
175242
News
May 3, 2024
27 mins ago
Assessing Sealed Air: Insights From 4 Financial Analysts
4 analysts have shared their evaluations of Sealed Air (NYSE:SEE) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 1 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 2 0 0 In the assessment of 12-month price targets, analysts unveil insights for Sealed Air, presenting an average target of $39.5, a high estimate of $44.00, and a low estimate of $36.00. The average price target has stayed the same, reflecting a consistent view from analysts. Diving into Analyst Ratings: An In-Depth Exploration A clear picture of Sealed Air’s perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target John Roberts Mizuho Lowers Neutral $36.00 $39.00 Michael Roxland Truist Securities Raises Buy $44.00 $39.00 Michael Roxland Truist Securities Lowers Hold $39.00 $40.00 John Roberts Mizuho Lowers Neutral $39.00 $40.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or …Full story available on Benzinga.com
175243
News
Copied
Related Events
No related events associated to this feed.
Latest Feed
May 3, 2024
26 mins ago
Alignment Healthcare Is ‘Differentiated With Durable Long-Term Growth Trajectory’ In Challenging Medicare Advantage Environment: Analyst Says
On Thursday, Alignment Healthcare Inc (NASDAQ:ALHC) reported a first-quarter EPS loss of $(0.25), up from $(0.20) a year ago, missing the consensus of $(0.22). The company reported sales of $628.6 million, up 43.1% Y/Y, beating the consensus of $595.13 million and the management guidance of $590 million-$600 million. The medical benefits ratio based on adjusted gross profit was 90.9%. Health plan membership at the end of the quarter was approximately 165,100, up 50.5% Y/Y. Guidance: Alignment Healthcare expects Q2 revenues of $625 million—$635 million versus the consensus of $608.65 million. The company raised its fiscal year 2024 sales outlook from $2.38 billion—$2.41 billion to $2.495 billion—$2.525 billion, compared to the …Full story available on Benzinga.com
ALHC
175241
News
May 3, 2024
27 mins ago
Analyst Expectations For Zimmer Biomet Holdings’s Future
In the last three months, 9 analysts have published ratings on Zimmer Biomet Holdings (NYSE:ZBH), offering a diverse range of perspectives from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 6 1 0 Last 30D 0 1 1 0 0 1M Ago 0 0 2 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 3 1 0 Analysts have set 12-month price targets for Zimmer Biomet Holdings, revealing an average target of $135.0, a high estimate of $155.00, and a low estimate of $125.00. Observing a 3.39% increase, the current average has risen from the previous average price target of $130.57. Decoding Analyst Ratings: A Detailed Look The standing of Zimmer Biomet Holdings among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Richard Newitter Truist Securities Lowers Hold $130.00 $137.00 Steven Lichtman Oppenheimer Raises Outperform $155.00 $150.00 Vijay Kumar Evercore ISI Group Raises In-Line $130.00 $125.00 Joanne Wuensch Citigroup Raises Neutral $140.00 $134.00 Caitlin Cronin Canaccord Genuity Maintains Hold $130.00 – Matt Miksic Barclays Raises Underweight $130.00 $120.00 Richard Newitter Truist Securities Raises Hold $135.00 $133.00 Robbie Marcus JP Morgan Raises Neutral $125.00 $115.00 Shagun Singh RBC Capital Maintains Outperform $140.00 – Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, it reflects their response to recent developments related to Zimmer …Full story available on Benzinga.com
ZBH
175242
News
May 3, 2024
28 mins ago
Assessing Sealed Air: Insights From 4 Financial Analysts
4 analysts have shared their evaluations of Sealed Air (NYSE:SEE) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 1 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 2 0 0 In the assessment of 12-month price targets, analysts unveil insights for Sealed Air, presenting an average target of $39.5, a high estimate of $44.00, and a low estimate of $36.00. The average price target has stayed the same, reflecting a consistent view from analysts. Diving into Analyst Ratings: An In-Depth Exploration A clear picture of Sealed Air’s perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target John Roberts Mizuho Lowers Neutral $36.00 $39.00 Michael Roxland Truist Securities Raises Buy $44.00 $39.00 Michael Roxland Truist Securities Lowers Hold $39.00 $40.00 John Roberts Mizuho Lowers Neutral $39.00 $40.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they ‘Maintain’, ‘Raise’, or …Full story available on Benzinga.com
SEE
175243
News
Connect with your community
Introducing Audio Rooms: Engage in real-time discussions on community or news topics with fellow users. Each article or post can instantly create its exclusive audio room, facilitating conversations about subjects directly tied to the article or community post.
Audio Room Title:
Nvidia stock surges 25% the most in over 6 years, could it signal the start of AI bubble?
Someone already created an audio of this feed.
Join the room
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
How it Works
Seeking Alpha
Bezinga
Market Rebellion
Motley Fool
And More!
Not a TradeZing PLUS Member?
Subscribe now for exclusive advantages and benefits!
0 Comments